Year All20242023202220212020 Sep 24, 2024 Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference Read More Sep 03, 2024 Fractyl Health to Participate in Upcoming September Investor Conferences Read More Aug 14, 2024 Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates Read More Aug 08, 2024 Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure Read More Aug 07, 2024 Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024 Read More Jul 30, 2024 Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs Read More Jun 25, 2024 Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day Read More Jun 24, 2024 Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates Read More
Aug 14, 2024 Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
Aug 08, 2024 Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
Aug 07, 2024 Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Jul 30, 2024 Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
Jun 24, 2024 Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates